A Phase 3, Multi-Center, Open-Label Study to Assess the Diagnostic Performance and Clinical Impact of 18F-DCFPyL PET/CT Imaging Results in Men With Suspected Recurrence of Prostate Cancer

What is the purpose of this trial?

A Phase 3, Multi-Center, Open-Label Study to Assess the Diagnostic Performance and Clinical Impact of 18F-DCFPyL PET/CT Imaging Results in Men With Suspected Recurrence of Prostate Cancer


Participation Guidelines

Ages: 18 years and older

Gender: Male only


Progenics Pharmaceuticals

Start Date: 11/27/2018

End Date: 01/01/2020

Last Updated: 01/03/2019

Study HIC#: 2000024006